Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway.
about
Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cellsAutophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Management of intracranial melanomas in the era of precision medicine.Modulation of antitumor immunity with histone deacetylase inhibitors.
P2860
Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@ast
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@en
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@nl
type
label
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@ast
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@en
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@nl
prefLabel
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@ast
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@en
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@nl
P2093
P2860
P356
P1476
Histone deacetylase inhibitor ...... gulation of TRAIL/DR5 pathway.
@en
P2093
Ali R Jazirehi
James S Economou
Siavash K Kurdistani
P2860
P304
P356
10.4049/JIMMUNOL.1302532
P407
P577
2014-03-17T00:00:00Z